Table 3.
Hazard ratio and odds ratio of death and re-hospitalization among study population according to different categories of diuretic usages.
| Variables | Models | Diuretic agents | P | |
|---|---|---|---|---|
| Furosemide | Furosemide plus metolazone | |||
| Death | Univariate | 1.00 | 0.86 (0.68–1.10) | 0.241 |
| Multivariate ∗ | 1.00 | 0.78 (0.59–1.03) | 0.085 | |
|
| ||||
| Re-hospitalization | Univariate | 1.00 | 0.85 (0.66–1.10) | 0.224 |
| Multivariate ∗ | 1.00 | 0.80 (0.60–1.07) | 0.135 | |
∗Adjusted for age, sex, body mass index, ischemic heart disease, diabetes mellitus, hypertension, stroke, kidney diseases, chronic obstructive pulmonary disease, smoking, systolic blood pressure, diastolic blood pressure, heart rate, hemoglobin, sodium, potassium, blood urea nitrogen, creatinine, and discharged drug consumption (beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, digoxin, and nitrates).